CARES Hints Mortality Risk in CV Patients on Gout Med Febuxostat CARES Hints Mortality Risk in CV Patients on Gout Med Febuxostat

The mortality signal was something of a mystery as a secondary result. Febuxostat was primarily ' noninferior ' to allopurinol for safety in the patients with a history of cardiovascular disease.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news